Duration of Dual Antiplatelet Therapy and Long-Term Clinical Outcome After Coronary Drug-Eluting Stent Implantation

Author:

Tada Tomohisa1,Natsuaki Masahiro1,Morimoto Takeshi1,Furukawa Yutaka1,Nakagawa Yoshihisa1,Byrne Robert A.1,Kastrati Adnan1,Kadota Kazushige1,Iwabuchi Masashi1,Shizuta Satoshi1,Tazaki Junichi1,Shiomi Hiroki1,Abe Mitsuru1,Ehara Natsuhiko1,Mizoguchi Tetsu1,Mitsuoka Hirokazu1,Inada Tsukasa1,Araki Makoto1,Kaburagi Satoshi1,Taniguchi Ryoji1,Eizawa Hiroshi1,Nakano Akira1,Suwa Satoru1,Takizawa Akinori1,Nohara Ryuji1,Fujiwara Hisayoshi1,Mitsudo Kazuaki1,Nobuyoshi Masakiyo1,Kita Toru1,Kimura Takeshi1

Affiliation:

1. From the Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan (T.T., M.N., S.S., J.T., H.S., T. Kimura); Center for Medical Education and Clinical Epidemiology Unit, Graduate School of Medicine, Kyoto University, Kyoto, Japan (T.M.); Kobe City Medical Center General Hospital, Kobe, Japan (Y.F., N.E., T. Kita); Tenri Hospital, Tenri, Japan (Y.N.); Deutsches Herzzentrum, Munich, Germany (R.A.B., A.K.); Kurashiki Central Hospital, Kurashiki, Japan (K.K., K...

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference16 articles.

1. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention);Smith SC;Circulation.,2005

2. Long-term safety and efficacy of sirolimus-eluting stents versus bare-metal stents in real world clinical practice in Japan

3. Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation

4. Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents

5. Six-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3